Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

UNIFIED · Unifying Framework for Patient-centred Clinical-study Endpoints derived from Digital Health Technologies

HORIZONStatus: SIGNED1 November 202531 October 2030EU funding €12,600,000Call HORIZON-JU-IHI-2024-08-two-stage

Motivation: Failing to incorporate patient perspectives in healthcare decisions leads to sub-optimal care. Despite increasing emphasis from industry and policy-makers this is not yet common practice. Main objectives: UNIFIED is a public-private partnership involving universities, industry, patient groups, medical centres, HTA bodies, and clinical guideline organisations. It is designed to generate a UNIFIED Framework for obtaining a robust view of a health intervention’s full benefits to patients via (i) integrating three key data types: patient preference information, clinical outcome assessments, and digital health technology (DHT)-derived measures, and (ii) determining what patients consider minimum clinically important difference. Leveraging cutting-edge AI, particularly Foundation Models, UNIFIED integrates these diverse patient-centred data types reliably, while employing advanced safeguards. UNIFIED uses a structured, interactive, and multimethod approach, fostering synergy between academic expertise and fast experience in pharmaceutical and MedTech industry. Validation of the initial framework will occur through well-aligned complementary use cases in five medical domains across Europe and Canada and an adoption approach for patients, caregivers, clinicians, industry, regulatory/HTA/reimbursement bodies.Main deliverables: A robust evidence- and consensus-based UNIFIED Framework with recommendations for integrating patient-centred clinical-study endpoints. The framework will provide clear, actionable guidance for timely and effective use of patient-centred, DHT-derived data as clinical endpoints.Expected long-term impact: Through its evidence- and consensus-based framework and recommendations, UNIFIED empowers patients, caregivers, clinicians, industry, regulatory/HTA/reimbursement bodies to make patient-centred healthcare decisions. This will drive measurable improvements across the healthcare ecosystem, benefitting patients, caregivers, clinicians, industry, regulatory/HTA/reimbursement bodies, and society. Ultimately, UNIFIED will enhance patient-centred care by ensuring healthcare decisions reflect true value to patients, thus improving patient outcomes, while ensuring healthcare’s long-term effectiveness and economic sustainability.

Consortium · 51 organisations

coordinator

ERASMUS UNIVERSITEIT ROTTERDAM

NL · €3,079,810

participant

SIEMENS HEALTHINEERS AG

DE

associatedPartner

PFIZER PHARMA GMBH

DE

participant

MEDIZINISCHE UNIVERSITAET WIEN

AT · €600,140

associatedPartner

EVINOVA AB

SE

associatedPartner

PFIZER LIMITED

UK

associatedPartner

JANSSEN CILAG LIMITED

UK

participant

MOLNLYCKE HEALTH CARE AB

SE

participant

HUS-YHTYMA

FI · €599,918

participant

H2O PAN EUROPEAN OBSERVATORY

DK · €140,000

participant

ABBVIE INC

US

participant

ISTITUTO EUROPEO DI ONCOLOGIA SRL

IT · €300,000

associatedPartner

Pfizer International Operations

FR

participant

EUROPEAN ACADEMY OF NEUROLOGY

AT · €80,000

participant

UCB BIOPHARMA

BE

participant

PANCARE

NL · €79,875

participant

FORUM DES PATIENTS EUROPEENS

BE · €329,500

associatedPartner

Janssen Research & Development, LLC

US

participant

9197-1168 QUEBEC IN

CA

participant

PROMPTLY - SOFTWARE SOLUTIONS FOR HEALTH MEASURES SA

PT · €450,000

participant

John Snow Labs Inc.

US

participant

NOVARTIS PHARMA AG

CH

participant

UNIVERSITEIT TWENTE

NL · €1,099,996

participant

ASTRAZENECA AB

SE

associatedPartner

AstraZeneca Pharmaceuticals LP

US

associatedPartner

IQVIA LTD

UK

associatedPartner

Amgen Inc

US

participant

AMGEN

BE

participant

F. HOFFMANN-LA ROCHE AG

CH

participant

Cassie and Friends: A Society for Children with Juvenile Arthritis and other Rheumatic Diseases

CA · €80,000

associatedPartner

Varian Medical Systems Inc.

US

participant

UNIVERSITAIR MEDISCH CENTRUM UTRECHT

NL · €112,878

participant

CHILDHOOD CANCER INTERNATIONAL

NL · €128,563

participant

ASSOCIATION EUROPEENNE POUR LA MALADIE DE PARKINSON

BE · €80,000

participant

PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV

NL · €487,475

participant

UNIVERSITY OF CALGARY

CA · €956,768

participant

UNIVERSITA DEGLI STUDI DI MILANO

IT · €299,175

participant

THE EUROPEAN COALITION FOR PEOPLE LIVING WITH OBESITY COMPANY LIMITED BY GUARANTEE

IE · €80,000

participant

HOCHSCHULE NEUBRANDENBURG

DE · €599,602

participant

PFIZER INC

US

participant

IQVIA SOLUTIONS BELGIUM

BE

participant

FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS

IT · €600,000

participant

The Hospital for Sick Children

CA · €16,290

participant

NOVO NORDISK A/S

DK

participant

KATHOLIEKE UNIVERSITEIT LEUVEN

BE · €600,000

participant

FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD M.P.

ES · €250,000

participant

JANSSEN BIOLOGICS BV

NL

participant

COLLABORATE PROJECT MANAGEMENT GMBH

DE · €300,000

participant

UNIVERSITEIT VAN AMSTERDAM

NL · €650,013

associatedPartner

Pfizer R&D UK Limited

UK

participant

UNIWERSYTET JAGIELLONSKI

PL · €600,000

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.